These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 2893260)

  • 21. [Use of polymorphous DNA probes in the study of French families with Huntington's chorea].
    Lucotte G; Berriche S; Burckel A; Turpin JC
    Rev Neurol (Paris); 1990; 146(4):303-5. PubMed ID: 1972803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presymptomatic, prenatal, and exclusion testing for Huntington disease using seven closely linked DNA markers.
    Skraastad MI; Verwest A; Bakker E; Vegter-van der Vlis M; van Leeuwen-Cornelisse I; Roos RA; Pearson PL; van Ommen GJ
    Am J Med Genet; 1991 May; 39(2):217-22. PubMed ID: 1829584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presymptomatic testing for Huntington's disease. Emotional aspects.
    Zak JP; Zaglul JT; Mueller OT; Diamond T
    J Fla Med Assoc; 1994 Feb; 81(2):109-12. PubMed ID: 8169585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Psychosocial aspects in presymptomatic testing for genetic diseases. Experiences after 2 years of counseling in Huntington disease].
    Blomhoff S; Malt U; Weisaeth L
    Tidsskr Nor Laegeforen; 1995 Jan; 115(1):27-9. PubMed ID: 7846655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence of presymptomatic cognitive decline in Huntington's disease.
    Diamond R; White RF; Myers RH; Mastromauro C; Koroshetz WJ; Butters N; Rothstein DM; Moss MB; Vasterling J
    J Clin Exp Neuropsychol; 1992 Nov; 14(6):961-75. PubMed ID: 1452640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethical considerations of genetic presymptomatic testing for Huntington's disease.
    Coustasse A; Pekar A; Sikula A; Lurie S
    J Hosp Mark Public Relations; 2009; 19(2):129-41. PubMed ID: 19827323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presymptomatic testing for Huntington's disease by linkage and by direct mutation analysis: comparison of uptake of testing and characteristics of test applicants.
    Holloway SM; Porteous ME; Fitzpatrick DR; Crosbie AE; Cetnarskyj R; Warner J; Barron L
    Genet Couns; 1998; 9(2):103-11. PubMed ID: 9664206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Attitudes regarding molecular diagnosis in Mexican families at risk of inheriting Huntington's disease.
    Garcia de la Cadena C; Alonso ME; Ochoa A; Martinez C
    Arch Med Res; 1997; 28(4):513-6. PubMed ID: 9428575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive testing for Huntington's disease using linked DNA markers.
    Hayden MR; Bloch M; Fahy M
    N Engl J Med; 1988 Sep; 319(9):583-4. PubMed ID: 2970011
    [No Abstract]   [Full Text] [Related]  

  • 30. Presymptomatic testing for Huntington's disease. A case complicated by recombination within the D4S10 locus.
    Curtis A; Millan F; Holloway S; Mennie M; Crosbie A; Raeburn JA; Brock DJ
    Hum Genet; 1989 Jan; 81(2):188-90. PubMed ID: 2563253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations in using linkage analysis as a presymptomatic test for Huntington's disease.
    Farrer LA; Myers RH; Cupples LA; Conneally PM
    J Med Genet; 1988 Sep; 25(9):577-88. PubMed ID: 2903248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presymptomatic testing for Huntington's disease.
    Bird SJ
    JAMA; 1985 Jun; 253(22):3286-91. PubMed ID: 3158756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal and adult presymptomatic testing for Huntington's disease.
    Turner DR; Haan EA; Jacka E; Kalucy RS; Burns RJ; Willoughby JO; Crabb R
    Med J Aust; 1988 Jun; 148(11):567, 570-3. PubMed ID: 2897620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Predictive testing: presymptomatic diagnosis in neurogenetic disorders].
    Dürr A; Gargiulo M; Feingold J
    Med Sci (Paris); 2005 Nov; 21(11):934-9. PubMed ID: 16274644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Studies on DNA markers (D4S10 and D4S43/S127) genetically linked to Huntington's disease in Japanese families.
    Kanazawa I; Kondo I; Ikeda JE; Ikeda T; Shizu Y; Yoshida M; Narabayashi H; Kuroda S; Tsunoda H; Mizuta E
    Hum Genet; 1990 Aug; 85(3):257-60. PubMed ID: 1975553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predictive testing for Huntington's disease: ten years' experience in two Italian centres.
    Mandich P; Jacopini G; Di Maria E; Sabbadini G; Abbruzzese G; Chimirri F; Bellone E; Novelletto A; Ajmar F; Frontali M
    Ital J Neurol Sci; 1998 Apr; 19(2):68-74. PubMed ID: 10935839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Are there neuropsychologic manifestations of the gene for Huntington's disease in asymptomatic, at-risk individuals?
    Strauss ME; Brandt J
    Arch Neurol; 1990 Aug; 47(8):905-8. PubMed ID: 1973893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clustering of multiallele DNA markers near the Huntington's disease gene.
    MacDonald ME; Cheng SV; Zimmer M; Haines JL; Poustka A; Allitto B; Smith B; Whaley WL; Romano DM; Jagadeesh J
    J Clin Invest; 1989 Sep; 84(3):1013-6. PubMed ID: 2569477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease.
    Grafton ST; Mazziotta JC; Pahl JJ; St George-Hyslop P; Haines JL; Gusella J; Hoffman JM; Baxter LR; Phelps ME
    Ann Neurol; 1990 Nov; 28(5):614-21. PubMed ID: 1979723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Huntington's disease: predictive testing and the molecular genetics laboratory.
    Lazarou LP; Meredith AL; Myring JM; Tyler A; Morris M; Ball DM; Harper PS
    Clin Genet; 1993 Mar; 43(3):150-6. PubMed ID: 8098998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.